Stocks
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 22.3 | 12.0 | 9.97 | -4.24 | 12.5 | 3.43 | ||
| Changes by years, y/y, % | -52% | -46% | -17% | -143% | -394% | -23.0% | |||
Vanda Pharmaceuticals. EV/EBITDA
Vanda Pharmaceuticals. EV/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -131.6 | 12.2 | 7.09 | 1.90 | 3.04 | 3.43 | |
| Changes by years, y/y, % | -1 331% | -379% | -224% | -121% | -102% | |||
| Changes by quarters, q/q, % | +1 369% | -109% | -42% | -73% | +60% | |||
